课题基金 / 基金详情

Using nanopocket membranes to capture bacterial outer membrane vesicles from biofluids

Using nanopocket membranes to capture bacterial outer membrane vesicles from biofluids
使用纳米袋膜从生物液中捕获细菌外膜囊泡
批准号:
10425443
负责人:
THOMAS R GABORSKI
金额:
$18.44万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-09 至 2024-05-31

项目摘要

项目成果

THOMAS R GABORSKI的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY Sepsis is not only the most expensive condition treated in US hospitals, but also a leading cause of death. Sepsis occurs when host pro-inflammatory immune responses become abnormally elevated due to a dysregulated or aberrant host-response to infection. Diagnostic methods for sepsis can vary between hospitals, but often involve scoring systems (e.g. APACHE II and SOFA) that grade the severity of illness in patients. Many of the altered physiological parameters measured by these scoring systems are not necessarily specific to sepsis, which makes it difficult to diagnose sepsis in early stages. Timing of a patient’s sepsis diagnosis is often predictive of their clinical outcome, underlining the need for a more definitive molecular diagnostic test. However, a recent study found that in the majority (70.1%) of sepsis cases, a specific causal organism could not be determined, likely due to aggressive antibiotics or localized infections. Bacterial outer membrane vesicles (OMVs) are attractive diagnostic biomarkers because of: A) their abundance and ability to circulate throughout the body and pass tissue barriers more easily than bacteria themselves; B) their robustness - unlike their bacterial cell “parent,” OMVs can withstand the inundation of broad-spectrum antibiotics; and C) their unique features that could allow for differentiation between bacterial species. The objective of this proposal is two-fold: Identify whether bacterial OMVs could be a molecular diagnostic biomarker for sepsis and develop a rapid approach to isolate them from patient plasma. We seek to develop a straightforward high-purity and rapid separation technology that effectively isolates and purifies OMVs from biofluids, including plasma. We will implement a modified tangential flow filtration approach, similar to those used by biopharma for high-capacity and high- yield purification, with a new nanopocket membrane that effectively captures and releases bacterial OMVs with minimal loss. Success of these aims will pave the way for the future development of a one-step, point-of-care diagnostic test for sepsis using bacterial OMVs as the molecular biomarker, as well a more complex diagnostic test that more accurately quantifies OMV levels in the patient’s biofluids to help direct early treatment and reduce mortality. This project will be led by an interdisciplinary team of experts in identifying potential biomarkers in E. coli; membranes, materials, and bioseparations; and a critical care physician scientist.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
The Effect of Antibiotics on Outer Membrane Vesicle Production.
抗生素对外膜囊泡产生的影响。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Dinu,MilenaA, Michel,Lea, Gaborski,Thomas, Perdue,Janai, Kasper,Anna, Morehouse,Ryan]
通讯作者: Morehouse,Ryan
Triggering toxicity: How antibiotics can enhance the release of outer membrane vesicles from Escherichia coli during sepsis.
引发毒性:抗生素如何在败血症期间增强大肠杆菌外膜囊泡的释放。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Michel,LeaV, Konovalova,Anna, Hellman,Judith, Gaborski,Thomas]
通讯作者: Gaborski,Thomas
Optimizing the production, purification, characterization of E. coli OMVs.
优化大肠杆菌 OMV 的生产、纯化和表征。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Kasper,Anna, Henretta,Sarah, Dinu,Milena, Smith,Callum, Videva,Martina, Crawford,Jamie, Shanahan,Caitlin, Gaborski,Thomas, Michel,LeaV]
通讯作者: Michel,LeaV
Investigating the Application of Size-Exclusion Chromatography to Purify Bacterial Extracellular Vesicles.
研究尺寸排阻色谱法在纯化细菌细胞外囊泡中的应用。
DOI: --
发表时间: 2022
期刊: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子: --
作者: [Gaborski,Thomas, Guernsey,Cara, Henretta,Sara, Hosseinifakhr,Atiyeh, Torabian,Pantea, Kasper,Anna, Michel,Lea]
通讯作者: Michel,Lea
Development of size-selective capture and release membranes for purification of extracellular vesicles
  • 批准号:
    10631914
  • 项目类别:
  • 资助金额:
    $18.5万
  • 财政年份:
    2022
  • 负责人:
    THOMAS R GABORSKI
  • 依托单位:
Development of size-selective capture and release membranes for purification of extracellular vesicles
  • 批准号:
    10432803
  • 项目类别:
  • 资助金额:
    $22.19万
  • 财政年份:
    2022
  • 负责人:
    THOMAS R GABORSKI
  • 依托单位:
Using nanopocket membranes to capture bacterial outer membrane vesicles from biofluids
  • 批准号:
    10288527
  • 项目类别:
  • 资助金额:
    $23.26万
  • 财政年份:
    2021
  • 负责人:
    THOMAS R GABORSKI
  • 依托单位:
Plasma clearance of water soluble and albumin bound toxins using graphene oxide nanoengineered laminates
  • 批准号:
    9387567
  • 项目类别:
  • 资助金额:
    $23.23万
  • 财政年份:
    2017
  • 负责人:
    THOMAS R GABORSKI
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: